Proactiveinvestors United Kingdom Physiomics PLC https://www.biotech-capital.com Proactiveinvestors United Kingdom Physiomics PLC RSS feed en Fri, 22 Nov 2019 06:17:17 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Physiomics traded in line with expectations https://www.biotech-capital.com/companies/news/224686/physiomics-traded-in-line-with-expectations-224686.html Tue, 30 Jul 2019 06:11:00 +0100 https://www.biotech-capital.com/companies/news/224686/physiomics-traded-in-line-with-expectations-224686.html Physiomics technology to be used to analyse Bicycle Therapeutics and Cancer Research UK cancer study https://www.biotech-capital.com/companies/news/223470/physiomics-technology-to-be-used-to-analyse-bicycle-therapeutics-and-cancer-research-uk-cancer-study-223470.html Mon, 08 Jul 2019 06:29:00 +0100 https://www.biotech-capital.com/companies/news/223470/physiomics-technology-to-be-used-to-analyse-bicycle-therapeutics-and-cancer-research-uk-cancer-study-223470.html Physiomics’ Virtual Tumour software starting to gain traction in world of oncology https://www.biotech-capital.com/companies/news/223444/physiomics-virtual-tumour-software-starting-to-gain-traction-in-world-of-oncology-223444.html Fri, 05 Jul 2019 05:30:00 +0100 https://www.biotech-capital.com/companies/news/223444/physiomics-virtual-tumour-software-starting-to-gain-traction-in-world-of-oncology-223444.html Physiomics wins fourth immune-oncology contract for virtual tumour software https://www.biotech-capital.com/companies/news/223039/physiomics-wins-fourth-immune-oncology-contract-for-virtual-tumour-software-223039.html Fri, 28 Jun 2019 09:17:00 +0100 https://www.biotech-capital.com/companies/news/223039/physiomics-wins-fourth-immune-oncology-contract-for-virtual-tumour-software-223039.html Physiomics spies possible ‘nearer-term’ revenues from latest cancer tool https://www.biotech-capital.com/companies/news/220192/physiomics-spies-possible-nearer-term-revenues-from-latest-cancer-tool-220192.html Tue, 14 May 2019 07:00:00 +0100 https://www.biotech-capital.com/companies/news/220192/physiomics-spies-possible-nearer-term-revenues-from-latest-cancer-tool-220192.html Renewal of key Merck contract caps off “strong” first half for Physiomics https://www.biotech-capital.com/companies/news/215037/renewal-of-key-merck-contract-caps-off-strong-first-half-for-physiomics-215037.html Thu, 21 Feb 2019 10:21:00 +0000 https://www.biotech-capital.com/companies/news/215037/renewal-of-key-merck-contract-caps-off-strong-first-half-for-physiomics-215037.html Physiomics striking up new relationships in world of oncology https://www.biotech-capital.com/companies/news/211910/physiomics-striking-up-new-relationships-in-world-of-oncology-211910.html Thu, 03 Jan 2019 12:45:00 +0000 https://www.biotech-capital.com/companies/news/211910/physiomics-striking-up-new-relationships-in-world-of-oncology-211910.html Physiomics hails the potential of new alliance https://www.biotech-capital.com/companies/news/211880/physiomics-hails-the-potential-of-new-alliance-211880.html Thu, 03 Jan 2019 11:10:00 +0000 https://www.biotech-capital.com/companies/news/211880/physiomics-hails-the-potential-of-new-alliance-211880.html Physiomics extends lucrative relationship with Merck https://www.biotech-capital.com/companies/news/211311/physiomics-extends-lucrative-relationship-with-merck-211311.html Mon, 17 Dec 2018 08:34:00 +0000 https://www.biotech-capital.com/companies/news/211311/physiomics-extends-lucrative-relationship-with-merck-211311.html Physiomics reports record year of income with significant contract wins https://www.biotech-capital.com/companies/news/310799/physiomics-reports-record-year-of-income-with-significant-contract-wins-10799.html Wed, 10 Oct 2018 11:25:00 +0100 https://www.biotech-capital.com/companies/news/310799/physiomics-reports-record-year-of-income-with-significant-contract-wins-10799.html Physiomics’ annual revenue doubles thanks to lucrative Merck KGaA contract win https://www.biotech-capital.com/companies/news/206553/physiomics-annual-revenue-doubles-thanks-to-lucrative-merck-kgaa-contract-win-206553.html Mon, 08 Oct 2018 06:51:00 +0100 https://www.biotech-capital.com/companies/news/206553/physiomics-annual-revenue-doubles-thanks-to-lucrative-merck-kgaa-contract-win-206553.html Physiomics zips higher with trading ahead of expectations https://www.biotech-capital.com/companies/news/199298/physiomics-zips-higher-with-trading-ahead-of-expectations-199298.html Thu, 21 Jun 2018 07:21:00 +0100 https://www.biotech-capital.com/companies/news/199298/physiomics-zips-higher-with-trading-ahead-of-expectations-199298.html Physiomics ready to build on Merck Serono landmark https://www.biotech-capital.com/companies/news/196925/physiomics-ready-to-build-on-merck-serono-landmark-196925.html Mon, 14 May 2018 12:11:00 +0100 https://www.biotech-capital.com/companies/news/196925/physiomics-ready-to-build-on-merck-serono-landmark-196925.html Physiomics PLC: Personalised medicines will build on momentum from recent pharma deals https://www.biotech-capital.com/companies/news/309204/physiomics-plc-personalised-medicines-will-build-on-momentum-from-recent-pharma-deals-9204.html Thu, 03 May 2018 12:40:00 +0100 https://www.biotech-capital.com/companies/news/309204/physiomics-plc-personalised-medicines-will-build-on-momentum-from-recent-pharma-deals-9204.html Physiomics lands pre-clinical contract for virtual tumour tech https://www.biotech-capital.com/companies/news/190677/physiomics-lands-pre-clinical-contract-for-virtual-tumour-tech-190677.html Fri, 26 Jan 2018 08:16:00 +0000 https://www.biotech-capital.com/companies/news/190677/physiomics-lands-pre-clinical-contract-for-virtual-tumour-tech-190677.html Physiomics and Merck team up to progress Virtual Tumour technology https://www.biotech-capital.com/companies/news/187923/physiomics-and-merck-team-up-to-progress-virtual-tumour-technology-187923.html Tue, 28 Nov 2017 15:50:00 +0000 https://www.biotech-capital.com/companies/news/187923/physiomics-and-merck-team-up-to-progress-virtual-tumour-technology-187923.html Physiomics shares advance as it signs Merck deal https://www.biotech-capital.com/companies/news/66744/physiomics-shares-advance-as-it-signs-merck-deal-77885.html Tue, 03 Mar 2015 15:05:00 +0000 https://www.biotech-capital.com/companies/news/66744/physiomics-shares-advance-as-it-signs-merck-deal-77885.html Physiomics rockets after signing first big pharma customer https://www.biotech-capital.com/companies/news/51902/physiomics-rockets-after-signing-first-big-pharma-customer-61691.html AIM-listed Physiomics doubled in value in the space of 15 minutes after the company won its first large pharma customer for modelling cardiac toxicity risk

]]>
Tue, 01 Oct 2013 11:20:00 +0100 https://www.biotech-capital.com/companies/news/51902/physiomics-rockets-after-signing-first-big-pharma-customer-61691.html
Physiomics lands first commercial partner for Virtual Tumour https://www.biotech-capital.com/companies/news/48424/physiomics-lands-first-commercial-partner-for-virtual-tumour-57713.html Thu, 06 Jun 2013 06:52:00 +0100 https://www.biotech-capital.com/companies/news/48424/physiomics-lands-first-commercial-partner-for-virtual-tumour-57713.html Physiomics wins contract from 'top five pharma company', shares soar https://www.biotech-capital.com/companies/news/39074/physiomics-wins-contract-from-top-five-pharma-company-shares-soar-46676.html Fri, 10 Aug 2012 08:08:00 +0100 https://www.biotech-capital.com/companies/news/39074/physiomics-wins-contract-from-top-five-pharma-company-shares-soar-46676.html Physiomics shares plummet on news full-year results hit by project delays https://www.biotech-capital.com/companies/news/37702/physiomics-shares-plummet-on-news-full-year-results-hit-by-project-delays-45072.html Wed, 04 Jul 2012 15:00:00 +0100 https://www.biotech-capital.com/companies/news/37702/physiomics-shares-plummet-on-news-full-year-results-hit-by-project-delays-45072.html Physiomics shares soar on contract win from further global pharma group https://www.biotech-capital.com/companies/news/33308/physiomics-shares-soar-on-contract-win-from-further-global-pharma-group-39672.html Thu, 01 Mar 2012 10:17:00 +0000 https://www.biotech-capital.com/companies/news/33308/physiomics-shares-soar-on-contract-win-from-further-global-pharma-group-39672.html Physiomics shares up 24 pct after new deal with Eli Lilly https://www.biotech-capital.com/companies/news/29358/ Wed, 02 Nov 2011 08:42:00 +0000 https://www.biotech-capital.com/companies/news/29358/ Physiomics shares soar on positive results of pre-clinical in-vivo breast cancer study https://www.biotech-capital.com/companies/news/22621/physiomics-shares-soar-on-positive-results-of-pre-clinical-in-vivo-breast-cancer-study-26963.html Fri, 01 Apr 2011 11:14:00 +0100 https://www.biotech-capital.com/companies/news/22621/physiomics-shares-soar-on-positive-results-of-pre-clinical-in-vivo-breast-cancer-study-26963.html Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groups https://www.biotech-capital.com/companies/news/21977/physiomics-reports-difficult-trading-but-highlights-growing-interest-from-big-pharmaceutical-groups-26218.html Wed, 09 Mar 2011 08:06:00 +0000 https://www.biotech-capital.com/companies/news/21977/physiomics-reports-difficult-trading-but-highlights-growing-interest-from-big-pharmaceutical-groups-26218.html Physiomics and partner Jubilant Biosys to commence commercial discussions https://www.biotech-capital.com/companies/news/21940/physiomics-and-partner-jubilant-biosys-to-commence-commercial-discussions-26164.html Tue, 08 Mar 2011 08:04:00 +0000 https://www.biotech-capital.com/companies/news/21940/physiomics-and-partner-jubilant-biosys-to-commence-commercial-discussions-26164.html